by Deepak Tyagi | Aug 31, 2022 | current affairs
Bharat Biotech as of late looked for endorsement for its intranasal Covid vaccine candidate, BBV154, as two-dose immunization as well as booster dosage. It submitted information from Stage 3 clinical trials of BBV154 to look for approval. Key Attributes – An...
